Prognostic value of biomarkers in ischemic stroke

Time codes:
  • 00:00:15

    Introduction to ischemic stroke and the importance of biomarkers for diagnosis and treatment

  • 00:01:01

    The relevance of the stroke problem

  • 00:03:46

    Definition of biomarkers

  • 00:06:54

    Practical application of biomarkers in stroke

  • 00:13:03

    Sources of biomarkers

  • 00:15:37

    Examples of biomarkers

  • 00:21:37

    Promising "omics" technologies for the search for new biomarkers

  • 00:23:42

    Biomarker-based therapy directions

  • 00:26:00

    Mexidol as an example of a neuroprotector with proven effectiveness

Lecturer: Shchukin Ivan Aleksandrovich - PhD, Associate Professor of the Department of Neurology, Neurosurgery and Medical Genetics of the Leningrad Branch of the N.I. Pirogov Russian National Research Medical University.

Announcement:

Key topics for discussion:

Key topics for discussion:

  • Relevance of the problem and statistics;
  • Definition of biomarkers and their importance;
  • Promising biomarkers;
  • The future lies in omics technologies (proteomics, metabolomics), which allow the analysis of thousands of molecules for personalized therapy;
  • Clinical applications (neuroprotection and targeted therapy).

Biomarkers are the key to accurate diagnosis and personalized treatment of stroke!

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com